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Polyacrylamide gel electrophoresis of fluorophore-
labeled hyaluronan and chondroitin sulfate
disaccharides: Application to the analysis in cells
and tissues
This report describes a new formulation of polyacrylamide gel electrophoresis of fluor-
ophore-labeled saccharides (PAGEFS) for the analysis of hyaluronan (HA) and chon-
droitin sulfate (CS) D-disaccharides. PAGEFS relies on derivatization of reducing ends
of HA- and the variously sulfated CS-derived D-disaccharides with 2-aminoacridone
(AMAC), followed by electrophoresis under optimized buffer conditions (Tris-borate
and Tris-HCl) and on polyacrylamide gels (25% T/3.75% C). The method was applied
to the analysis of glycosaminoglycans (GAGs) from the human umbilical cord tissue
and GAGs isolated from human aortic smooth muscle cell cultures. The obtained
results were in agreement with those obtained after an analysis with high-performance
liquid chromatography (HPLC). On the basis of these results, PAGEFS is a rapid and
sensitive method for the analysis of the total amount of HA- and CS-derived disaccha-
rides, as it allows analyzing 20 samples in minigels in one run and provides quantitation
with relatively high sensitivity (less than 25 pmol per disaccharide). In addition,
PAGEFS overcomes the lack of commercial gels described previously for the separa-
tion of AMAC-labeled disaccharides. Therefore, the method proposed here is an eco-
nomic and useful tool for a fast screening of GAGs in biological samples, particularly
when a high number of samples should be analyzed.
Keywords:Chondroitin sulfate disaccharides / Human aortic smoothmuscle cells / Human umbil-
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1 Introduction
Glycosaminoglycans (GAGs) are linear heteropolysac-
charides composed of repeating disaccharide units.
They can be divided into four main categories: (i) hyaluro-
nan (HA), (ii) chondroitin sulfate (CS) and dermatan sulfate
(DS), (iii) heparan sulfate (HS) and heparin, and (iv) keratan
sulfate. With the exception of HA, GAGs contain sulfate
residues and are covalently bound to a protein core, con-
stituting proteoglycans (PGs), which are the main com-
plex macromolecules of many extracellular matrices
(ECMs). They play important biological roles as they par-
ticipate in and regulate many cellular events, including
cell proliferation, migration, and adhesion [1]. CS, usually
referred to as galactosaminoglycan (GalAG), consists of a
repeating disaccharide unit that contains an uronic acid
glycosidically linked to a galactosamine residue. It is a
highly charged polymer due to the presence of esterified
sulfate groups at one or more available hydroxyl groups
on the disaccharide [2]. CS sulfated at the C-4 and the
C-6 positions of N-acetylated galactosamine (GalNAc)
are predominant GAGs in the ECM of the arterial wall,
and the modification of Ddi-mono4S/Ddi-mono6S ratio
plays a critical role in diseases [3–6]. HA is the simplest
GAG since none of the hydroxyl groups are esterified
with sulfates. Its structure differs from CS in that the Gal-
NAc is replaced withN-acetylated glucosamine (GlcNAc).
It is not covalently bound to a protein core, but it forms
aggregates with PGs of high molecular size, such as
aggrecan and versican. It plays an important role in cellu-
lar events, in embryonic and tissue development as well
as in tumorigenesis and in several diseases [7].
Since CS and HA are components with high importance
in biological events, we developed a technique for the
analysis of D-disaccharides obtained after polysaccha-
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ride chain digestion with specific enzymes. This method
involves derivatization of the enzymatically released
unsaturated disaccharides with the fluorophore 2-ami-
noacridone (AMAC), followed by electrophoresis in mini-
slab polyacrylamide gel. Polyacrylamide gel electropho-
resis of fluorophore-labeled saccharides (PAGEFS) has
been previously described for analysis of N-linked gly-
cans of mammalian [8], as well as fluorophore-assisted
carbohydrate electrophoresis (FACE) for analysis of total
hyaluronan and chondroitin sulfate [9, 10] and polysac-
charide analysis using carbohydrate gel electrophoresis
(PACE) for analysis of plant polysaccharides [11]. Gel
electrophoresis using minislab gels is a relatively eco-
nomical, easy, and fast method. Many samples can be
analyzed in parallel, giving it the potential for a high
throughput, and quantitation of a total amount of GAGs
is determined when standards are analyzed in the same
gel.
The aim of this study is to present a new formulation of
polyacrylamide gel electrophoresis useful for GAG analy-
sis, and to compare the results of this technique with
those of the well-established HPLC. The sensitivity of the
developed PAGEFS method was found to be less than
25 pmol per disaccharide. Both separation techniques
were applied to the analysis of HA and CS isolated from
human umbilical cord and cultured human aortic smooth
muscle cells (AoSMCs). It was worth studying these sam-
ples, as changes in CS and HA content in the ECM are
involved in several pathologic conditions in the human
umbilical cord and arterial wall [4, 12].
2 Materials and methods
2.1 Chemicals and biological materials
Standard preparations of 2-acetamido-2-deoxy-3-O-(4-
deoxy-a-L-threo-hex-4-enopyranosyluronic acid)-D-glu-
cose [Ddi-nonSHA], 2-acetamido-2-deoxy-3-O-(4-deoxy-
2-O-sulfo-a-L-threo-hex-4-enopyranosyluronic acid)-4-
O-sulfo-D-galactose [Ddi-di(2,4)S], 2-acetamido-2-deoxy-
3-O-(4-deoxy-a-L-threo-hex-4-enopyranosyluronic acid)-
4-O-sulfo-D-galactose [Ddi-mono4S], 2-acetamido-2-
deoxy-3-O-(4-deoxy-a-L-threo-hex-4-enopyranosyluro-
nic acid)-6-O-sulfo-D-galactose [Ddi-mono6S], 2-aceta-
mido-2-deoxy-3-O-(4-deoxy-2-O-sulfo-a-L-threo-hex-4-
enopyranosyluronic acid)-D-galactose [Ddi-mono2S]
and 2-acetamido-2-deoxy-3-O-(4-deoxy-a-L-threo-hex-4-
enopyranosyluronic acid)-D-galactose [Ddi-nonSCS] were
all purchased from Sigma (St. Louis, MO, USA). Protease
K (EC 3.4.21.64) was from Finnzymes (Espoo, Finland).
Hyaluronidase SD (EC 3.2.1.35) and chondroitinase ABC
(EC 4.2.2.4) were from Seikagaku Kogyo (Tokyo, Japan).
AMAC was obtained fromMolecular Probes (Eugene, OR,
USA) and NaBH3CN from Sigma-Aldrich (Steinheim, Ger-
many). Tris was from Fluka Chemie (Buchs, Switzerland)
and acetonitrile from Merck (Darmstadt, Germany). Acryl-
amide and N,N’-methylenebisacrylamide were obtained
from Bio-Rad (Richmond, CA, USA), TEMED from BDH
Chemicals (Poole, England), and ammonium persulfate
from LKB (Bromma, Sweden). All aqueous solutions were
prepared using water filtered through a Milli-Q water sys-
tem (Millipore, Bedford, MA, USA). All other chemicals
usedwere of analytical reagent grade.
2.2 Derivatization procedure
Derivatization of standard HA and CS D-disaccharides
was done as described by Calabro et al. [13]. In particular,
10 nmol of each standard D-disaccharide in water was
completely evaporated in a microcentrifuge tube at
11 0006g at room temperature. A 40 mL volume of
12.5 mM AMAC solution in glacial acetic acid/DMSO
(3:17 v/v) was added, and samples were incubated for
10–15 min at room temperature. A 40 mL volume of a
freshly prepared solution of 1.25 M NaBH3CN in water
was added to each sample followed by an overnight incu-
bation at 377C.
2.3 Preparation of polyacrylamide gel
A MiniProtean II cell vertical slab gel electrophoresis
apparatus (Bio-Rad) was used with 7.2 cm plates,
0.75 mm spacer, and wells of 0.5 cm. The stock buffer
solutions were 1.5 M Tris-borate, pH 8.8, and 1.5 M Tris-
HCl, pH 8.8. Acrylamide solution 50% T/7.5%C for the
resolving gel and 50% T/15%C for the stacking gel were
used as stock solutions.% T refers to the total concentra-
tion (w/v) of acrylamide monomer (i.e. acrylamide plus
methylenebisacrylamide);% C refers to the concentration
(w/v) of cross-linker relative to the total monomer. A 10mL
volume of 25% T/3.75%C resolving gel, in 187.5 mM Tris-
borate and 187.5 mM Tris-HCl buffer solution (final con-
centrations) was prepared and degassed. A 5 mL volume
of TEMED and a 50 mL volume of a freshly prepared 10%
w/v ammonium persulfate were added. The solution was
mixed rapidly and then placed between the glass plates,
avoiding air bubbles. The nonpolymerized gel was over-
laid with butanol. Polymerization occurred within
,20 min. The gel can be used immediately or stored at
47C for 1–2 weeks. The resolving gel upper surface was
rinsed with stacking gel buffer (0.15 M Tris-HCl diluted
from the stock solution). A 5 mL volume of 5% T/1.5% C
acrylamide stacking gel in 0.36 M Tris-HCl buffer solution
was prepared, followed by an addition of 10 mL TEMED
and 50 mL 10% ammonium persulfate. Immediately the
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solution was poured on the top of the resolving gel and
the well-forming comb was inserted. The height of the
stacking gel was 5 mm, and the polymerization required
,45 min.
2.4 Electrophoresis of D-disaccharides
Immediately before electrophoresis, the wells were rinsed
with the electrophoresis buffer (0.15 M Tris-borate, pH 8.8).
A prerun of the gel was done at 400 Vand 47C for 10min in
order to stabilize the current. A 5 mL volume of each sam-
ple, supplemented with glycerol in a final concentration of
20% v/v, was loaded in each well. A marker sample con-
taining bromophenol blue was also run in a well with no
sample. Electrophoresis was done at 400 V and 47C and
terminated when the marker dye was 1.2 mm from the
bottom of the gel (,35 min).
2.5 Gel imaging and product quantitation
Gels were scanned in a UV-light box using a CCD camera
(Gel Doc 2000 System) from Bio-Rad Laboratories. Iden-
tification and quantitation of sample bands were done by
comparing their migration and the pixel density with
standard D-disaccharides, running in the same gel.
2.6 HPLC analysis
Separation and analysis of AMAC-derivatives of D-disac-
charides were done with a Jasco-Borwin chromatograph
system with a fluorophore detector (Jasco FP-920, lex =
442 nm and lem = 520 nm). Chromatography was carried
out using a reversed-phase column (C-18, 4.66150 mm;
Bischoff) at room temperature, equilibrated with 0.1 M
ammonium acetate, pH 7.0, filtered through a 0.45 mm
membrane filter. A gradient elution was done using a bi-
nary solvent system composed of 0.1 M ammonium ace-
tate, pH 7.0 (eluent A), and acetonitrile (eluent B). The flow
rate was 1 mL/min, and the following program was used:
prerun of column with 100% eluent A for 20 min, isocratic
elution with 100% eluent A for 5 min, gradient elution to
30% eluent B for 30 min and from 30% to 50% for 5 min.
Sample peaks were identified and quantified comparing
the fluorescence spectra with standard D-disaccharides,
using Jasco-Borwin software.
2.7 Cell culture
Human aortic smooth muscle cells (AoSMCs) and their
growth medium Bulletkit-2 (SmGM-2) were obtained
from Clonetics (BioWhittaker, Walkersville, MD, USA)
as well as all the other reagents. Cells (105) were seeded
in a T-25 flask, and the growth medium was changed
daily. The cells were subcultured at early confluence using
trypsin/EDTA. The trypsin was inactivated with trypsin
neutralize solution (TNS), and the number of cells in sus-
pension was determined using a Burker chamber. A num-
ber of 56104 cells was seeded in a well plate, and the
culture was maintained at 377C (5% CO2 in air with 90%
humidity) in the SmGM-2 medium. The medium was
changed daily over a week. Cell-layer samples and media
were harvested daily. Cell-layer samples were extracted
with 2% SDS.
2.8 Isolation and degradation of GAGs from cell
culture and tissue
Medium and cell-layer extracts from the cell cultures were
frozen at 2807C and lyophilized in a microfuge tube at
room temperature. Each pellet was dissolved in 300 mL
water followed by an addition of 96% ethanol (or absolute
ethanol) in a ratio of 1:4. The mixtures were precipitated
overnight at2207C. Following centrifugation at 11 0006g
at 47C for 15 min, the pellets were left to dry and then
digested with protease K. In particular, the pellet was dis-
solved in 300 mL 100 mM ammonium acetate buffer,
pH 7.0, containing 20 U/mL protease K, and digestion
was done at 607C for 2 h. The enzymic treatment was ter-
minated by boiling for 5 min. Thereafter, 4 volumes of
96% ethanol per sample volume was added, and the
GAGs in the mixture were precipitated at 2207C over-
night. Fresh human umbilical cord samples (50 mg) were
digested at 607C for 2 h in 300 mL 100 mM ammonium ac-
etate buffer, pH 7.0, containing 20 U/mL protease K. The
enzymic treatment was terminated by boiling for 5 min.
Four volumes of 96% ethanol per sample volume was
added, and the GAGs in the mixture were precipitated at
2207C overnight. Ethanol-precipitated GAGs were centri-
fuged at 110006g at 47C for 15 min. The obtained pellets
were dried and dissolved in 100 mL 100 mM ammonium
acetate, pH 7.0, containing 100 mU/mL hyaluronidase
SD and digested at 377C for 1 h. A 100 mU/mL
chondroitinase ABC was added, and the mixture was
incubated at 377C for 3 h. The samples were then frozen
at 2807C and then lyophilized. The D-disaccharide
digested products were then derivatized as described
above.
3 Results and discussion
It has already been reported that derivatization of HA and
CS D-disaccharides with AMAC improve dramatically the
detection sensitivity of various separation techniques,
such as HPLC, FACE, and CZE [13–15]. Derivatization
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with AMAC has also been recently used to study polysac-
charides found in plant walls [11]. This method allows the
labeling of the reducing ends of unsaturated disaccha-
rides obtained after enzymic degradation of GAG chains
[16]. The amino group of AMAC reacts with the carbonyl
group of the reducing end of the disaccharide moiety to
form a Schiff’s base, further reduced with sodium cyano-
borohydride to form a stable secondary amine [14].
AMAC derivatives are stable for months when stored at
2807C [17].
3.1 Optimization of gel electrophoresis
Gel electrophoresis was optimized for HA and variously
sulfated CS D-disaccharides. The gels used always con-
sisted of a stacking gel and a resolving gel. The stacking
gel is important as it facilitates the uniform entry of sam-
ples into the resolving gel and furthermore retards the
excess AMAC. Following pilot experiments it was found
that the optimal heights of the stacking and resolving
gels were 5 mm and 5.5 cm, respectively. In order to opti-
mize the electrophoretic conditions, various running con-
ditions were tested. These involved the percentage of
acrylamide in the gels, the concentration of N,N’-meth-
ylenebisacrylamide in the gels and the type of electropho-
resis buffer. All values of the acrylamide concentration be-
tween 25 and 30% in the resolving gel separated comple-
tely the disaccharides tested (data not shown). However,
the concentration of the cross-linker (N,N’-methylenebis-
acrylamide) was crucial for effective separation. Four dif-
ferent concentrations of cross-linkers were tested in the
resolving gel: (i) 25% T/2.5% C, (ii) 25% T/3.75%C,
(iii) 25% T/5% C, and (iv) 25% T/7.5% C. The results
showed that the gel composed of 25% T/3.75% C
ensured the best separation of the D-disaccharides
(Fig. 1). Gels with a higher concentration of cross-linker
were less efficient (data not shown). The ratios that were
examined for the stacking gel were: (i) 5% T/0.5% C,
(ii) 5% T/1%C, (iii) 5% T/1.5% C. The optimal value was
5% T/1.5% C, indicating that the cross-linker concentra-
tion was also crucial in the stacking gel (data not shown).
As shown in Fig. 2, almost identical molar fluorescence
was obtained for both Ddi-nonSHA and Ddi-nonSCS. The
r2 = 0.987 value of PAGEFS was comparable with that
obtained from HPLC analysis (r2 = 0.990).
The choice of the electrophoresis buffer was critical for
the effective separation of all types of D-disaccharides.
Different types of buffers have been used for stacking
and resolving gels as well as for the running buffer. The
best separation was obtained using a buffer composed
of 187.5 mM Tris-HCl and 187.5 mM Tris-borate buffer,
pH 8.8, for resolving gel polymerization. Higher concen-
Figure 1. Analysis of standard HA and variously sulfated
CS D-disaccharides, derivatized with AMAC, by poly-
acrylamide gel electrophoresis. Analysis was done on a
25%T/3.75%C polyacrylamide gel with a stacking gel of
5%T/1.5%C, at 400 V, at 47C for 45 min. The electropho-
resis buffer was 0.15 M Tris-borate, pH 8.8; the resolving
gel buffer was amix of 187.5mM Tris-borate and 187.5mM
Tris-HCl, pH 8.8; the stacking gel buffer was 0.36 M Tris-
HCl, pH 8.8. (A) Lane 1, mixture of D-disaccharides;
2, Ddi-nonSHA; 3, Ddi-nonSCS; 4, Ddi-mono4S; 5, Ddi-
mono6S; 6, Ddi-di(2,4)S; 7, Ddi-mono2S.
Figure 2. Quantitation of AMAC-derivatized Ddi-nonSHA
and Ddi-nonSCS after separation by PAGEFS. Mixtures
containing 5–75 pmol each of the indicated AMAC deriva-
tives were separated by PAGEFS. The gel was then
imaged using a CCD camera, and the images analyzed
using a Gel Doc program and Microsoft Excel (r2 = 0.987).
trations of resolving gel buffer increased the heat forma-
tion during the run. The use of a buffer containing both
Tris-HCl and Tris-borate is critical. In fact, it has already
been demonstrated that Tris-HCl buffer in the resolving
and stacking gel can separate successfully highly sul-
fated heparan sulfate oligosaccharides [18] and various
sulfated CS D-disaccharides [19]. The separation of sul-
fated D-disaccharides using this buffer was actually very
efficient, but the separation of nonsulfated CS and HA
D-disaccharides was very poor (Fig. 3, lane 2). Nonsul-
fated D-disaccharides were successfully separated using
a Tris-borate buffer, as described previously [20] (Fig. 3,
lane 3), but the separation of sulfated D-disaccharides
was not complete. The effect of the borate buffer on di-
saccharide separation was described in CE analysis by
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Figure 3. Analysis of standard HA and variously sulfated
CS D-disaccharides followed by derivatization with
AMAC, with various buffer conditions in the resolving gel.
The stacking gel consisted of polyacrylamide 5%T/
1.5%C in a 0.36 M Tris-HCl buffer, pH 8.8, and the running
buffer was 0.15 M Tris-borate, pH 8.8. The resolving gel
consisted of 25%T/3.75%C. Resolving buffers: lane 1,
187.5 mM Tris-borate and 187.5 mM Tris-HCl, pH 8.8;
2, 0.375 M Tris-HCl, pH 8.8; 3, 0.375 M Tris-borate, pH 8.8;
4, 0.375 M Tris-borate and 0.375 M Tris-HCl, pH 8.3.
Lamari and Karamanos [21], who demonstrated that car-
bohydrates can form anion complexes with borate under
alkaline conditions, thus offering a better separation be-
tween nonsulfated D-disaccharides. Based on these
observations, a buffer containing both Tris-HCl and Tris-
borate in the resolving gel was used. Using this mixed
buffer, the separation of sulfated and nonsulfated D-di-
saccharides in the same run was achieved (Fig. 1). Differ-
ent stacking gel and running buffer formulations were
tested; the optimal choice of stacking gel buffer was
0.36 M Tris-HCl, pH 8.8, and the best formulation for run-
ning buffer was 0.15 M Tris-borate, pH 8.8 (Fig. 3, lane 1).
Lower pH on the buffers reduced the efficiency of separa-
tion of sulfated disaccharides (Fig. 3, lane 4).
3.2 Application to the analysis of GAGs from
human umbilical cord cultured and AoSMCs
and comparison with HPLC
The method was applied to study HA and CS D-disac-
charides isolated from a tissue (human umbilical cord)
and a cell culture (AoSMCs), as described in Section 2
(Fig. 4A and Fig. 5A, respectively). Results of analysis of
human umbilical cord disaccharides are shown in lane 2
of Fig. 4. Disaccharide separation identified and quanti-
fied disaccharides derived from HA and CS-4 and CS-6
sulfated chondroitin sulfate. As expected, the HA disac-
charide is mainly represented (about 70% of total disac-
Figure 4. GAGs isolated from fresh human umbilical cord
were digested with hyaluronidase SD and chondroitinase
ABC. The products were derivatized with AMAC and ana-
lyzed with PAGEFS and HPLC. (A) PAGEFS conditions in
Fig. 1. Lane 1, mixture containing 100 pmol of each stand-
ard D-disaccharide; 2, D-disaccharide derived from hu-
man umbilical cord. (B) HPLC analysis was performed
with a reversed-phase column (C-18, 4.66150 mm), and
the products were detected with a fluorophore detector
(lex = 442 nm and lem = 520 nm). Separation of standard
(profile 1) and derived (profile 2) D-disaccharides from hu-
man umbilical cord. Peaks: I, Ddi-di(2,4)S; II, Ddi-
mono4S; III, Ddi-mono6S; IV, Ddi-nonSHA; V, Ddi-nonSCS.
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Figure 5. GAGs from the medium and the cell layer of
AoSMCs were isolated and digested with hyaluronidase
SD and chondroitinase ABC. The products were deriva-
tized with AMAC and analyzed with PAGEFS and HPLC.
(A) PAGEFS conditions analysis as in Fig. 1. Lane 1, mix-
ture containing 100 pmol of each standard D-disaccha-
ride; 2, derivatized D-disaccharides from the medium of
AoSMCs; 3, derivatized D-disaccharides from the cell
layer of AoSMCs. (B) HPLC analysis was performed as
described in Fig. 4. Profile 1, HPLC analysis of a mixture
of standard D-disaccharides; profile 2, 3, separation of
derived D-disaccharides from the medium and cell layer
of AoSMCs, respectively. Peaks: I, Ddi-di(2,4)S; II, Ddi-
mono4S; III, Ddi-mono6S; IV, Ddi-nonSHA; V, Ddi-nonSCS.
charides), whereas DDi4S and DDi6S are almost in
equal amounts. The separation and quantitation of di-
saccharides were confirmed by HPLC analysis (Fig. 4B,
profile 2).
As far as the AoSMC disaccharides are concerned,
PAGEFS separations are summarized in Fig. 5. PAGEFS
results were in agreement with those of HPLC and
showed that HAwas particularly abundant in the medium,
constituting 70% of the total amount of GAG (Fig. 5A,
lane 2; Fig. 5B, profile 2). The DDi4S/DDi6S ratios in
PAGEFS and HPLC were 2.1:1 and 2.3:1, respectively.
The peak II in Fig. 5B was Ddi-mono2S. That was identi-
fied after co-injection of a sample with a commercial
standard. CS present in the culture medium is mainly sul-
fated at C-4. As expected, only very small amounts of HA
and CS were detected in the cell layer (Fig. 5A, lane 3;
Fig. 5B, profile 3).
4 Concluding remarks
We described a powerful and flexible PAGEFS method to
analyze HA- and CS-derived disaccharides after their
derivatization with the fluorophore AMAC. The utility of
this gel system is evident considering the lack of commer-
cial gels described by Calabro et al. [9, 10, 13] that are not
longer available. The procedure proposed here is simple
and rapid since 20 samples can be analyzed in one run
(two minigels in one apparatus), requiring only 2 h for gel
preparation and ,1 h for electrophoresis. Moreover, this
technique is of low cost since it does not require expen-
sive equipment, in contrast to other approaches for car-
bohydrate analysis. The method has high sensitivity (less
than 25 pmol of derived D-disaccharides can be detect-
ed), and provides a fast and accurate tool for estimating
the total amount of HA and various sulfated CS disac-
charides in a small quantity of material. The applicability
was examined by analyzing successfully the GAG-
derived D-disaccharides from the culture medium and
cell layer of a AoSMC culture and from human umbilical
cord. The efficiency of themethod was evaluated by com-
paring the results obtained from the analysis by PAGEFS
with those by HPLC, which is a well accepted method for
disaccharide analysis. The HPLC equipped with fluores-
cence detector achieves a higher sensitivity compared to
PAGEFS, since Ddi-mono2S was detected only using
HPLC. However, the latter technique requires more ex-
pensive equipment, HPLC runs are longer, only single
samples can be analyzed at a time, and more sample vol-
ume is necessary. The data obtained suggest that the
PAGEFS method may be a useful tool for a fast and sen-
sitive screening of multiple samples.
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